<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of protein kinase C (PKC) in mediating the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced release of amino acids in the striatum was studied using an in vivo brain dialysis technique in the striatum of spontaneously hypertensive rats (SHRs) </plain></SENT>
<SENT sid="1" pm="."><plain>Using HPLC combined with fluorescence detection methods, we investigated the concentrations of amino acids in the dialysates produced by 20 min of transient forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We studied the effects of an inhibitor of PKC, <z:chebi fb="0" ids="43385">1-(5-isoquinolinesulfonyl)-2-methylpiperazine</z:chebi> dihydrochloride (H7) and another <z:chebi fb="0" ids="16092">isoquinoline</z:chebi> analog (HA1004) with less inhibitory effect on the C kinase in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced amino acids release </plain></SENT>
<SENT sid="3" pm="."><plain>Bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> caused a marked reduction in the striatal blood flow by 91 +/- 6% </plain></SENT>
<SENT sid="4" pm="."><plain>The extent of the cerebral blood flow (CBF) reduction were essentially the same among H7-, HA1004-, and the vehicle-treated groups </plain></SENT>
<SENT sid="5" pm="."><plain>Forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> produced a marked increase in <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (21-fold of the basal concentration), <z:chebi fb="0" ids="29995">aspartate</z:chebi> (19-fold) and <z:chebi fb="5" ids="15891">taurine</z:chebi> (16-fold) </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with H7 markedly attenuated the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-in-duced release of these three amino acids to 3, 3 and 4-fold of the basal values, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Increase of <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>) was also attenuated by H7 (vehicle; 2.46 +/- 1.26 microM, H7; 0.62 +/- 0.75 mM) </plain></SENT>
<SENT sid="8" pm="."><plain>HA1004 did not affect the release of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>, <z:chebi fb="0" ids="29995">aspartate</z:chebi> or <z:chebi fb="3" ids="16865">GABA</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced release of <z:chebi fb="5" ids="15891">taurine</z:chebi> was significantly inhibited by HA1004 but the effect was much smaller than that of H7 </plain></SENT>
<SENT sid="10" pm="."><plain>These results thus indicate that PKC plays a major role in the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced release of amino acids in the striatum of SHR </plain></SENT>
</text></document>